“Global Biosimilars and Follow-On Biologics Drugs market set to grow to $14bn by 2024” says new Visiongain report

21 March 2019
Pharma

Visiongain has launched a new pharma report Global Biosimilars and Follow-On Biologics Market : Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones.

Many companies are chasing development of the same biosimilar targets, which could lead to heavily fragmented markets if multiple therapies are approved. Although this occurs in the small molecule generics market, it will prove to be more of a challenge for biosimilars. There developers need to receive sufficient uptake to recoup the high development and manufacturing costs of biosimilars.

Uptake of biosimilars varies greatly between different regions, and marketing and education campaigns will be needed to combat this and convince consumers, doctors and healthcare payers of the benefits of biosimilars.

The lead analyst of the report commented "Growth will be restrained in the biosimilar growth hormones submarket by steady uptake for branded therapies, high brand loyalty, as well as the launch of long-acting growth hormones. Rising diabetes incidence will drive demand for biosimilar human insulin in emerging markets, while the launch of biosimilar insulin glargine in developed markets during the forecast period will drive growth in the biosimilar insulin analogues sector."

Leading companies featured in the report include Biocon Limited, Biogen Idec Inc., Bioton, Celltrion Pharm, Inc., Dong-A Pharmaceutical Co., Ltd., Dr.Reddy's Labs (DRL), Genentech (Roche Group), Hexal AG, Hospira, Intas Pharmaceuticals Ltd., LG Life Sciences and others.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

Read

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever